---
title: "Sunresin Technology invests in the establishment of a new materials company"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/256051233.md"
description: "According to the Qichacha APP, recently, Pu Cheng Lan Xiao Bio-materials Co., Ltd. was established, with Tian Xiaojun as the legal representative and a registered capital of 20 million yuan. The business scope includes: manufacturing of synthetic materials; sales of synthetic materials; research and development of new material technology; promotion services for new material technology, etc. Qichacha's equity penetration shows that the company is wholly owned by Lan Xiao Technology"
datetime: "2025-09-05T03:03:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/256051233.md)
  - [en](https://longbridge.com/en/news/256051233.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/256051233.md)
generator: "portal-rs"
---

# Sunresin Technology invests in the establishment of a new materials company

According to the Qichacha APP, recently, Pucheng Lanxiao Biotech New Materials Co., Ltd. was established, with Tian Xiaojun as the legal representative and a registered capital of 20 million yuan. The business scope includes: manufacturing of synthetic materials; sales of synthetic materials; research and development of new material technology; promotion services for new material technology, etc. Qichacha's equity penetration shows that the company is wholly owned by Lanxiao Technology through indirect holdings

### Related Stocks

- [300487.CN](https://longbridge.com/en/quote/300487.CN.md)

## Related News & Research

- [JDC: Record growth in turnover and EBITDA, with strong outlook driven by new regulation and AI](https://longbridge.com/en/news/296247395.md)
- [Demant hearing care chief Niels Wagner sells shares worth DKK 1.47 million](https://longbridge.com/en/news/296345010.md)
- [Moody's Affirms CATL  A3 Issuer Rating, Outlook Revised to Positive](https://longbridge.com/en/news/296605274.md)
- [Frozen blueberries recall categorized under FDA's highest Class I risk level](https://longbridge.com/en/news/296506599.md)
- [NIO: PFS confirms strong project economics, resource growth, and new revenue streams, with DFS ahead](https://longbridge.com/en/news/296469016.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**